Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07775807

Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder

The goal of this clinical trial is to evaluate whether closed-loop theta-burst stimulation (TBS) targeting the right parietal-occipital cortex (rPO) can improve core clinical symptoms in individuals with methamphetamine use disorder (MUD), such as cue-reactivity and impaired inhibitory control.

The main questions it aims to answer are:

Can closed-loop rPO-TBS significantly reduce cue-reactivity, as measured by a Visual Analog Scale (VAS) and a cue-reactivity task? Does closed-loop stimulation enhance cognitive control, assessed by performance on the Stop Signal Task (SST)?

Researchers will administer closed loop TBS to determine whether it can improve the core symptoms of MUD.

Participants will:

Complete a single closed-loop sessions. Receive theta-burst stimulation targeting the right parietal-occipital cortex while complete the cue-reactivity task.

Undergo cue-reactivity assessment using a Visual Analog Scale (VAS) and complete the Stop Signal Task (SST) before and after the stimulation session.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai Mental Health Center, 200030

Shanghai, Shanghai Municipality, 200000, China

Location contact

Min Zhao, PhD

CONTACT

[email protected]

18017311005

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years old or older, ....with at least 9 years of education (junior high school or above) or able to fully understand the task.
  • Meets DSM-5 for mild/severe amphetamine-type substance use disorder.
  • History of amphetamine-type substance use for no less than 1 year, with use at least once per week.
  • Has not received pharmacological treatment for substance use.

Exclusion criteria

  • Presence of any organic disease, or diagnosis of any other psychiatric disorder according to DSM-5 (e.g., bipolar disorder, major depression disorder).
  • Contraindications to TMS, as assessed by the Transcranial Magnetic Stimulation Adult Safety Screen (TASS).
  • Inability to complete assessments, treatment procedures, or follow-up due to cognitive or behavioral limitations.

Treatment and study plan

Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO

Device

Participants receive theta-burst stimulation (TBS) over the right parietal-occipital cortex (rPO), triggered by real time by EEG signals recorded during a cue-reactivity task. This closed-loop protocol aims to deliver stimulation precisely during neural states associated with cue-induced reactivity.

Other names: EEG-TMS, Closed-loop rPO-TBS

Primary outcomes

  1. Cue-Induced Neural Reactivity During Before and After Stimulation

    Time frame: During cue-reactivity task in training and stimulation phases of each session.

    EEG signals will be recorded while participants perform a cue-reactivity task during both the training phase (no stimulation) and the stimulation phase (with TBS). The primary outcome will be changes in cue-induced neural reactivity, defined by EEG features such as event-related potentials (ERPs) and power spectral density (e.g., theta or alpha power) in response to methamphetamine-related cues.

Secondary outcomes

  1. Change in Cue-Induced Craving Measured by Visual Analog Scale (VAS)

    Time frame: Before and within 30 minutes after stimulation

    Participants will rate their craving levels after viewing methamphetamine-related videos using a Visual Analog Scale (VAS), ranging from 0 (no craving) to 100 (maximum craving).

  2. Change in Inhibitory Control Assessed by Stop Signal Task (SST)

    Time frame: Before and within 30 minutes after stimulation

    Participants will complete the Stop Signal Task (SST) before and after each stimulation session. Measures such as Stop Signal Reaction Time (SSRT) and accuracy will be used to assess changes in inhibitory control performance.

Study contacts

Contact information is provided by the study sponsor or research team.

Min Zhao, PhD

CONTACT

[email protected]

+86 18017311005

Sponsors and collaborators

Lead sponsor

Shanghai Mental Health Center

Other

Registry information

Official study title

A Pilot Single-Arm Study of Closed-Loop TBS Theta-Burst Stimulation Targeting the Right Parietal-Occipital Cortex for Core Clinical Features of Methamphetamine Use Disorder

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 20, 2026
Registry last updated
Aug 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.